Sophie Putka is an enterprise and investigative writer for MedPage Today, with previous experience in health writing for Inverse and science writing for Discover Magazine. Her work focuses on a range of topics in the medical field, including access to medication, inappropriate use of drugs, and healthcare disparities.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Sophie's coverage heavily relies on data, suggesting she would be interested in pitches supported by robust and credible data or research. Given her focus on healthcare, medical procedures, research, ethics, and health conditions, she may be receptive to sources who can provide expert insights into these areas.
As Sophie covers a wide range of topics within the healthcare field without a specific geographic focus mentioned, consider providing her with diverse perspectives from experts across different regions when relevant. Additionally, given the scientific nature of much of her coverage, offering access to researchers or professionals involved in recent studies could make for compelling pitches.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Sophie Putka
— Health news and commentary gathered by MedPage Today staff Note that some links may require registration or subscription.
By: Sophie Putka
— Small study suggested benefits for MS patients with chronic optic neuropathy
By: Sophie Putka
— This past week in healthcare investigations Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
Losmapimod was associated with small improvements in fat infiltration, upper arm function
By: Sophie Putka
— LASTE trial builds on previous evidence favoring thrombectomy even in high-risk cases
— No, and physicians appear to have the lowest risk Alcohol-related deaths were not significantly higher for U.S. health workers compared
Three patients acquired Mycobacterium abscessus infections after medical travel
Declines aren't dramatic, but trans kids and healthcare providers are facing secondary challenges
— These drugs are only a part of gender-affirming care, but they hint at bigger changes over time
— Located near states with gender-affirming care bans, New Mexico acted to protect access
(833) 317-6278 
